Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4343 Target Snapshot

DNA polymerase beta · SINGLE PROTEIN · Rattus norvegicus

102Compounds
78Assays
0Approved Drugs
105.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P06766. Use UniProt P06766 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P06766 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA polymerase beta as ChEMBL target CHEMBL4343, mapped to UniProt P06766. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA polymerase beta
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL4343
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P06766
DNA polymerase beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA polymerase beta is the right protein anchor across sources, using UniProt P06766 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA polymerase beta
UniProt AccessionP06766
Component TypeProtein
Sequence Length335 aa

DNA polymerase beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA polymerase beta, mapped to UniProt P06766. Sequence length is 335 aa.

Mapped IDP06766
Review nameDNA polymerase beta
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5093.0
KI12.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL448072 5.92 IC50 1200.0 Preclinical
CHEMBL453751 5.7 IC50 2000.0 Preclinical
CHEMBL479472 5.6 IC50 2500.0 Preclinical
CHEMBL465365 5.57 IC50 2700.0 Preclinical
CHEMBL519411 5.55 Ki 2800.0 Preclinical
CHEMBL494656 5.54 IC50 2900.0 Preclinical
CHEMBL517522 5.5 IC50 3200.0 Preclinical
CHEMBL168 5.43 IC50 3700.0 Preclinical
CHEMBL3138225 5.33 Ki 4700.0 Preclinical
CHEMBL169 5.32 IC50 4800.0 Clinical
Distribution

pChEMBL Value Distribution

20
5.0
7
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

78
Total Assays
51
Tested Compounds
1
Assay Types
Binding — 78 assays, 51 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 74 46 4.9
assay format 2 1 4.5
cell-based format 2 4 4.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine